Ashraf A. Elshami
About
In The Last Decade
Ashraf A. Elshami
15 papers receiving 706 citations
Peers
Comparison fields: 5 of 59
- Genetics 456
- Molecular Biology 267
- Oncology 203
- Biotechnology 201
- Pulmonary and Respiratory Medicine 198
Countries citing papers authored by Ashraf A. Elshami
This map shows the geographic impact of Ashraf A. Elshami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf A. Elshami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf A. Elshami more than expected).
Fields of papers citing papers by Ashraf A. Elshami
This network shows the impact of papers produced by Ashraf A. Elshami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf A. Elshami. The network helps show where Ashraf A. Elshami may publish in the future.
Co-authorship network of co-authors of Ashraf A. Elshami
This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf A. Elshami. A scholar is included among the top collaborators of Ashraf A. Elshami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf A. Elshami. Ashraf A. Elshami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | A Very Rare Case of Sarcoid-Lymphoma Syndrome Imposing an Intriguing Diagnostic Challenge. | 0 |
| 4 | 167 | |
| 5 | Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma. | 96 |
| 6 | The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivo. | 26 |
| 7 | 44 | |
| 8 | 33 | |
| 9 | 33 | |
| 10 | 1 | |
| 11 | 25 | |
| 12 | 93 | |
| 13 | 80 | |
| 14 | 22 | |
| 15 | 77 | |
| 16 | 31 | |
| 17 | Bronchoalveolar lavage cytology in pulmonary sarcoidosis. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.